Hepatitis B surface antigen, hepatitis C and HIV antibodies in a low-risk blood donor group, Nigeria
AbstractWe investigated the seroprevalence of human immunodeficiency virus [HIV], hepatitis B virus [HBV] and hepatitis C virus [HCV] infection among 258 clergymen-in-training [age range 18-39 years] who represented a donor population that fulfilled the criteria for safe blood transfusion. In all, 15.1% of the men were positive for HBsAg, 4.3% were positive for anti-HCV and 2.7% were HIV- positive; 22.1% were infected with at least one of these viruses. Co-infection with HIV and HBV was found in 0.4% of the subjects, HBV and HCV in 0.4%, and HIV and HCV in 0%. This underscores the importance of routine screening of blood before transfusion, regardless of the donor background
Egah, D.Z., Banwat, E.B., Audu, E.S., Iya, D., Mandong, B.M. et al. (2007). Hepatitis B surface antigen, hepatitis C and HIV antibodies in a low-risk blood donor group, Nigeria. http://www.who.int/iris/handle/10665/117334
EMHJ - Eastern Mediterranean Health Journal, 13 (4), 961-966, 2007
MetadataShow full item record
Showing items related by title and MeSH subject.
Message from Dr Mahmoud Fikri Regional Director, WHO Eastern Mediterranean Region, on the occasion of World Hepatitis Day, 28 July 2017 World Health Organization, Regional Office for the Eastern Mediterranean (2017-07-28)
Message of Dr Ala Alwan WHO Regional Director for the Eastern Mediterranean on the occasion of World Hepatitis Day 2016 World Health Organization, Regional Office for the Eastern Mediterranean (2016-07)
Mastouri, M.; Safer, I.L.; Pozzetto, B.; Bourlet, T.; Khedher, M. (2005)Prevalence of hepatitis G virus among Tunisian blood donors Hepatitis G virus [GBV-C/HGV] is a recently identified virus which occurs worldwide. The prevalence of GBV-C/HGV in Tunisia has not been previously studied. We aimed to assess the prevalence of GBV-C/HGV infection in Tunisian blood donors. A total of 912 blood donors were tested for anti-E2 antibodies of GBV-C/HGV by enzyme-linked immunosorbent assay and 600 were tested by reverse transcriptase polymerase chain reaction. GBV-C/HGV RNA was found in 5.3% of the sample and HGV antibodies ...